COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
Since the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most countries, both mRNA and DNA vaccines have been administered, and their side effects have also been reported. The clinic...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academya Publishing Co.
2021-08-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.e-enm.org/upload/pdf/enm-2021-404.pdf |
id |
doaj-42cc96b4e4964248bf13e7a02b506f0d |
---|---|
record_format |
Article |
spelling |
doaj-42cc96b4e4964248bf13e7a02b506f0d2021-09-03T00:03:20ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782021-08-0136475776510.3803/EnM.2021.4042201COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine SocietyCheol Ryong Ku0Kyong Yeun Jung1Chang Ho Ahn2Jun Sung Moon3Ju Hee Lee4Eun Heui Kim5Hyemi Kwon6Hee Kyung Kim7Sunghwan Suh8Sangmo Hong9Jeonghoon Ha10Eun Roh11Jin Hwa Kim12Mi-kyung Kim13the Committee of Clinical Practice Guideline of the Korean Endocrine Society Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Korea Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, Korea Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea Department of Internal Medicine, Dong-A University Medical Center, Dong-A University College of Medicine, Busan, Korea Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Department of Internal Medicine, Chosun University Hospital, Chosun University College of Medicine, Gwangju, Korea Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, KoreaSince the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most countries, both mRNA and DNA vaccines have been administered, and their side effects have also been reported. The clinical course of COVID-19 and the effects of vaccination against COVID-19 are both influenced by patients’ health status and involve a systemic physiological response. In view of the systemic function of endocrine hormones, endocrine disorders themselves and the therapeutics used to treat them can influence the outcomes of vaccination for COVID-19. However, there are very limited data to support the development of clinical guidelines for patients with specific medical backgrounds based on large clinical trials. In the current severe circumstances of the COVID-19 pandemic, position statements made by clinical specialists are essential to provide appropriate recommendations based on both medical evidence and clinical experiences. As endocrinologists, we would like to present the medical background of COVID-19 vaccination, as well as precautions to prevent the side effects of COVID-19 vaccination in patients with specific endocrine disorders, including adrenal insufficiency, diabetes mellitus, osteoporosis, autoimmune thyroid disease, hypogonadism, and pituitary disorders.http://www.e-enm.org/upload/pdf/enm-2021-404.pdfadrenal insufficiencythyroiditis, autoimmunecovid-19 vaccinesdiabetes mellitusosteoporosishypogonadismhypopituitarismpituitary neoplasms |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cheol Ryong Ku Kyong Yeun Jung Chang Ho Ahn Jun Sung Moon Ju Hee Lee Eun Heui Kim Hyemi Kwon Hee Kyung Kim Sunghwan Suh Sangmo Hong Jeonghoon Ha Eun Roh Jin Hwa Kim Mi-kyung Kim the Committee of Clinical Practice Guideline of the Korean Endocrine Society |
spellingShingle |
Cheol Ryong Ku Kyong Yeun Jung Chang Ho Ahn Jun Sung Moon Ju Hee Lee Eun Heui Kim Hyemi Kwon Hee Kyung Kim Sunghwan Suh Sangmo Hong Jeonghoon Ha Eun Roh Jin Hwa Kim Mi-kyung Kim the Committee of Clinical Practice Guideline of the Korean Endocrine Society COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society Endocrinology and Metabolism adrenal insufficiency thyroiditis, autoimmune covid-19 vaccines diabetes mellitus osteoporosis hypogonadism hypopituitarism pituitary neoplasms |
author_facet |
Cheol Ryong Ku Kyong Yeun Jung Chang Ho Ahn Jun Sung Moon Ju Hee Lee Eun Heui Kim Hyemi Kwon Hee Kyung Kim Sunghwan Suh Sangmo Hong Jeonghoon Ha Eun Roh Jin Hwa Kim Mi-kyung Kim the Committee of Clinical Practice Guideline of the Korean Endocrine Society |
author_sort |
Cheol Ryong Ku |
title |
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society |
title_short |
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society |
title_full |
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society |
title_fullStr |
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society |
title_full_unstemmed |
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society |
title_sort |
covid-19 vaccination for endocrine patients: a position statement from the korean endocrine society |
publisher |
Academya Publishing Co. |
series |
Endocrinology and Metabolism |
issn |
2093-596X 2093-5978 |
publishDate |
2021-08-01 |
description |
Since the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most countries, both mRNA and DNA vaccines have been administered, and their side effects have also been reported. The clinical course of COVID-19 and the effects of vaccination against COVID-19 are both influenced by patients’ health status and involve a systemic physiological response. In view of the systemic function of endocrine hormones, endocrine disorders themselves and the therapeutics used to treat them can influence the outcomes of vaccination for COVID-19. However, there are very limited data to support the development of clinical guidelines for patients with specific medical backgrounds based on large clinical trials. In the current severe circumstances of the COVID-19 pandemic, position statements made by clinical specialists are essential to provide appropriate recommendations based on both medical evidence and clinical experiences. As endocrinologists, we would like to present the medical background of COVID-19 vaccination, as well as precautions to prevent the side effects of COVID-19 vaccination in patients with specific endocrine disorders, including adrenal insufficiency, diabetes mellitus, osteoporosis, autoimmune thyroid disease, hypogonadism, and pituitary disorders. |
topic |
adrenal insufficiency thyroiditis, autoimmune covid-19 vaccines diabetes mellitus osteoporosis hypogonadism hypopituitarism pituitary neoplasms |
url |
http://www.e-enm.org/upload/pdf/enm-2021-404.pdf |
work_keys_str_mv |
AT cheolryongku covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT kyongyeunjung covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT changhoahn covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT junsungmoon covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT juheelee covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT eunheuikim covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT hyemikwon covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT heekyungkim covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT sunghwansuh covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT sangmohong covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT jeonghoonha covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT eunroh covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT jinhwakim covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT mikyungkim covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety AT thecommitteeofclinicalpracticeguidelineofthekoreanendocrinesociety covid19vaccinationforendocrinepatientsapositionstatementfromthekoreanendocrinesociety |
_version_ |
1714314432054558720 |